Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
squamous cell cancer
Biotech
Acrivon snags $100M to bring Lilly cancer drug into 19th study
Prexasertib's 20-plus-year history gets new life with $100 million in funding to get the former Eli Lilly cancer drug across the FDA finish line.
Kyle LaHucik
Nov 11, 2021 8:00am
Kura surges on early readout in head and neck cancer trial
Sep 11, 2017 7:55am
IBM Research partners to find melanoma via cognitive computing
Jun 28, 2016 8:38am
